Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited BALANCE SHEET (All amounts in Indian Rupees millions, except share data and where otherwise stated) PARTICULARS NOTE AS AT 31 MARCH 2015 AS AT 31 MARCH 2014 EQUITY AND LIABILITIES Shareholders’ funds Share capital 2.1 852 851 Reserves and surplus 2.2 105,488 92,439 106,340 93,290 Non current liabilities Long term borrowings 2.3 9,391 9,015 Deferred tax liabilities, net 2.26 1,290 1,252 Other long term liabilities 2.4 255 47 Long term provisions 2.5 498 335 11,434 10,649 Current liabilities Short term borrowings 2.3 21,857 17,630 Trade payables 2.6 7,160 8,423 Other current liabilities 2.4 12,374 10,294 Short term provisions 2.5 5,395 4,795 46,786 41,142 TOTAL 164,560 145,081 ASSETS Non current assets Fixed assets Tangible assets 2.7 31,294 26,937 Intangible assets 2.7 1,200 546 Capital work-in-progress 4,883 5,761 Non current investments 2.8 17,601 17,401 Long term loans and advances 2.9 5,538 5,358 Other non current assets 2.15 11 - 60,527 56,003 Current assets Current investments 2.10 21,022 10,664 Inventories 2.11 17,233 15,921 Trade receivables 2.12 47,117 45,615 Cash and bank balances 2.13 9,014 6,651 Short term loans and advances 2.14 8,657 8,287 Other current assets 2.15 990 1,940 104,033 89,078 TOTAL 164,560 145,081 Significant accounting policies 1 The accompanying notes are an integral part of financial statements As per our report of even date attached for B S R & Co. LLP Chartered Accountants for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited Firm Registration No.: 101248W/W-100022 Supreet Sachdev Partner K Satish Reddy Chairman Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer Date : 12 May 2015 Sandeep Poddar Company Secretary 114
Standalone Financial Statements Annual Report 2014 - 15 STATEMENT OF PROFIT AND LOSS (All amounts in Indian Rupees millions, except share data and where otherwise stated) PARTICULARS NOTE FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 INCOME Sales, gross 99,703 95,777 Less: Excise duty (829) (820) Sales, net 98,874 94,957 Service income 247 335 License fees 154 1,176 Other operating revenue 2.16 835 812 Revenue from operations 100,110 97,280 Other income 2.17 2,228 1,515 Total revenue 102,338 98,795 EXPENSES Cost of material consumed (including packing material consumed) 22,484 21,918 Purchase of stock-in-trade 5,261 4,690 Changes in inventories of finished goods,work-in-progress and stock-intrade 2.18 (289) (1,706) Conversion charges 924 785 Employee benefits expense 2.19 14,909 14,199 Finance costs 2.20 638 783 Depreciation and amortisation expense 2.7 4,902 3,805 Other expenses 2.21 32,910 29,777 Total expenses 81,739 74,251 Profit before exceptional and extraordinary items and tax 20,599 24,544 Exceptional items - - Profit before extraordinary items and tax 20,599 24,544 Extraordinary items - - Profit before tax 20,599 24,544 Tax expense 2.22 Current tax expense 3,767 4,901 Deferred tax expense 38 315 Profit for the year 16,794 19,328 Earnings per share 2.24 Basic - Par value ` 5/- per share 98.60 113.67 Diluted - Par value ` 5/- per share 98.18 113.13 Number of shares used in computing earnings per share Basic 170,314,506 170,044,518 Diluted 171,056,969 170,857,689 Significant accounting policies 1 The accompanying notes are an integral part of financial statements As per our report of even date attached for B S R & Co. LLP Chartered Accountants for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited Firm Registration No.: 101248W/W-100022 Supreet Sachdev Partner K Satish Reddy Chairman Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer Date : 12 May 2015 Sandeep Poddar Company Secretary 115
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66: Statutory Reports • Corporate Gov
Page 73 and 74: Statutory Reports • Additional Sh
Page 87 and 88: Statutory Reports • Board’s Rep
Page 111 and 112: Standalone Financial Statements Ann
Page 115: Standalone Financial Statements Ann
Page 165 and 166: Consolidated Financial Statements A
Page 167 and 168:
Consolidated Financial Statements A
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Notice Annual Report 2014 - 15 NOTI
Page 229 and 230:
E-Voting Annual Report 2014 - 15 IN
Page 231:
Dr. Reddy’s Laboratories Limited
Page 235 and 236:
The future belongs, not to those wh
show all

Good Health Can’t Wait.

Create successful ePaper yourself

Delete template?

Save as template?